Quality by Design Approach for Hot-Melt Extrusion Coupled Fused Deposition Modeling (HME-FDM) 3D Printing: A Systematic Review
Open Access
- 2 May 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (5) , 569
Abstract
Background: Fused deposition modeling (FDM) is one of the most well-known and often published methods for 3D-printed drug delivery systems. In early scientific reports, the active pharmaceutical ingredients were added by soaking, but later, a new milestone was established, after researchers started to manufacture their own filaments by hot-melt extrusion (HME). The number of publications covering this method has multiplied in the last decade, a wide range of natural and synthetic polymers have been tested with versatile active pharmaceutical ingredient components, and various printing parameters and their effects have been investigated. Objectives: In this review, we aim to synthesize how the available quality by design approaches and the scientific results established so far can facilitate the creation of a guideline for appropriate quality production of HME-FDM 3D-printed pharmaceuticals. Methods: Based on PRISMA 2020 guidelines, a systematic search of relevant publications from 2015 to 2025 was carried out using the PubMed database. Twenty-six articles were included, based on number of monitored parameters and methodological description. Reporting of important quality processes and material parameters was assessed. Results: HME, the FDM, and analytical testing experiences were compared and collected into three tables from the selected publications. In two different sections, the pharmacopeial dosage-form tests and the involvement of process analytical technologies (PAT) were also analyzed. We found that reporting of influential parameters is heterogenous, and lack of robust reporting schemes limits the development of QbD approaches. Conclusions: Regarding the data, trends were synthetized, and a guideline was created which is limited by inconsistent parameter reporting.Keywords
Funding Information
- Ministry of Culture and Innovation of Hungary from the National Research, Development, and Innovation Fund (TKP2021-EGA)
- Magyar Tudományos Akadémia
This publication has 85 references indexed in Scilit:
- Toward a harmonized regulatory framework for 3D-printed pharmaceutical products: the role of critical feedstock materials and process parametersDrug Delivery and Translational Research, 2025
- Hot-melt extruded-FDM 3D-printed polyethylene oxide tablets: Dissolution imaging analysis of swelling and drug releaseEuropean Journal of Pharmaceutics and Biopharmaceutics, 2025
- Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug ReleasePharmaceutical Research, 2024
- Analysis of melting and flow in the hot-end of a material extrusion 3D printer using X-ray computed tomographyAdditive Manufacturing, 2023
- Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performanceAdvanced Drug Delivery Reviews, 2021
- 3D printing of tablets containing amorphous aripiprazole by filaments co-extrusionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2018
- Development of a Simple Mechanical Screening Method for Predicting the Feedability of a Pharmaceutical FDM 3D Printing FilamentPharmaceutical Research, 2018
- 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen releaseEuropean Journal of Pharmaceutical Sciences, 2018
- 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tabletsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- The pycnometer challengeAnalytical and Bioanalytical Chemistry, 2013